- Home
- ONEW vs ADCT Comparison
ONEW vs ADCT Comparison
Compare ONEW & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEW
- ADCT
- Stock Information
- Founded
- ONEW 2014
- ADCT 2011
- Country
- ONEW United States
- ADCT Switzerland
- Employees
- ONEW N/A
- ADCT N/A
- Industry
- ONEW Auto & Home Supply Stores
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- ONEW Consumer Discretionary
- ADCT Health Care
- Exchange
- ONEW Nasdaq
- ADCT Nasdaq
- Market Cap
- ONEW 244.4M
- ADCT 241.0M
- IPO Year
- ONEW 2020
- ADCT 2020
- Fundamental
- Price
- ONEW $15.30
- ADCT $3.17
- Analyst Decision
- ONEW Buy
- ADCT Strong Buy
- Analyst Count
- ONEW 7
- ADCT 6
- Target Price
- ONEW $19.83
- ADCT $7.80
- AVG Volume (30 Days)
- ONEW 138.6K
- ADCT 913.9K
- Earning Date
- ONEW 07-29-2025
- ADCT 08-05-2025
- Dividend Yield
- ONEW N/A
- ADCT N/A
- EPS Growth
- ONEW N/A
- ADCT N/A
- EPS
- ONEW N/A
- ADCT N/A
- Revenue
- ONEW $1,779,631,000.00
- ADCT $75,817,000.00
- Revenue This Year
- ONEW $1.60
- ADCT $11.75
- Revenue Next Year
- ONEW $3.33
- ADCT $10.29
- P/E Ratio
- ONEW N/A
- ADCT N/A
- Revenue Growth
- ONEW N/A
- ADCT 10.49
- 52 Week Low
- ONEW $11.58
- ADCT $1.05
- 52 Week High
- ONEW $31.00
- ADCT $4.13
- Technical
- Relative Strength Index (RSI)
- ONEW 56.73
- ADCT 59.73
- Support Level
- ONEW $14.13
- ADCT $2.66
- Resistance Level
- ONEW $16.20
- ADCT $3.30
- Average True Range (ATR)
- ONEW 0.83
- ADCT 0.20
- MACD
- ONEW 0.20
- ADCT 0.01
- Stochastic Oscillator
- ONEW 73.62
- ADCT 90.00
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).